Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof
AssigneeThe Regents of the University of California
InventorsThomas J. KIPPS, Jianqianq Yu
Life of this patent
Estimating the term…
Abstract
Compositions including an antibody single-chain variable fragment (scFv) conjugate that specifically binds to ROR1 tumor-associated antigen are provided. The anti-ROR1 scFv antibody and conjugates may include a biologically-active molecule. Such conjugates may comprise a chimeric receptor to direct T cells to respond to ROR1 cancer cells, Methods to use the scFV conjugates to target cells expressing ROR1 for therapeutic and diagnostic purposes are also provided.
Claims11
-37. (canceled)
A nucleic acid encoding a polypeptide comprising a single-chain variable fragment (scFv) comprising:
- a light chain variable region that comprises a CDR L1 corresponding to amino acid position 27-32 of SEQ ID NO:
- 2, a CDR L2 corresponding to amino acid position 50-52 of SEQ ID NO:
- 2, and a CDR L3 corresponding to amino acid position 89-97 of SEQ ID NO:
- 2;
- and
- a heavy chain variable region that comprises a CDR H1 corresponding to amino acid position 151-158 of SEQ ID NO:
- 2, a CDR H2 corresponding to amino acid position 176-182 of SEQ ID NO:
- 2, and a CDR H3 corresponding to amino acid position 223-233 of SEQ ID NO:
- 2, wherein said scFv is capable of binding receptor tyrosine kinase-like orphan receptor 1 (ROR1).
Dependencies are inferred from the claim text.